-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Atara Biotherapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2014 to Q2 2024.
- Atara Biotherapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $700K, a 22.2% decline year-over-year.
- Atara Biotherapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $3.5M, a 2.78% decline year-over-year.
- Atara Biotherapeutics, Inc. annual Depreciation for 2023 was $3.7M, a 21.3% decline from 2022.
- Atara Biotherapeutics, Inc. annual Depreciation for 2022 was $4.7M.
- Atara Biotherapeutics, Inc. annual Depreciation for 2016 was $383K, a 698% increase from 2015.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)